Analgesia Nociception Index In Pediatric Patients With Chronic Pain
Not yet recruitingNCT07145762
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
The goal of this observational study is to learn about the analgesia nociceptive index (ANI) is associated with pain sensitivity in patients between the ages of 9-17 who are experiencing chronic pain. The main question it aims to answer is: \- Does the ANI score correlate with the change in the pain sensitivity in patients aged 9-17 undergoing an interventional block. Patients already receiving an interventional block as part of their regular medical care for chronic pain will have their level of pain recorded during clinic appointments
Study details
- Official title
- Validity of the Analgesia Nociception Index in Children and Adolescents With Chronic Pain
- Conditions
- Interventions
- Procedure: Interventional Block
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Start date
- 2025-09-15
- Primary completion
- 2026-09-01
- Sex
- All
- Age range
- from 9 Years to 17 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Experiencing chronic pain defined by: persistent or recurrent pain at least once a week for at least three months in their electronic medical charts or by reference of the patient's physician Exclusion Criteria: * Taking medications known to affect the sympathetic or parasympathetic nervous systems such as cholinomimetics (e.g., pilocarpine), anticholinergics (e.g., ipratropium), sympathomimetics (e.g., salbutamol), and adrenergic antagonists (e.g., propranolol). * Diagnosed cardiac or neurological conditions, including patients with arrhythmias, heart block, postural orthostatic tachycardia syndrome, Guillain-Barre syndrome, or spinal cord injury. * Active cancer diagnosis * Conditions that may interfere with the ability to understand instructions or complete assessments including: cognitive, or developmental delay. * Patients who do not speak English or French.
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07145762